Adicet Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adicet Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q4 2024.
  • Adicet Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2024 was $14.2M, a 18.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $14.2M -$3.2M -18.3% Dec 31, 2024 10-K 2025-03-06
Q3 2024 $15.1M -$3.14M -17.2% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $15.9M -$3.08M -16.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $16.6M -$3.06M -15.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $17.4M -$2.85M -14% Dec 31, 2023 10-K 2025-03-06
Q3 2023 $18.2M -$2.81M -13.4% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $18.9M -$2.47M -11.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $19.7M -$5K -0.03% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $20.3M -$89K -0.44% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $21M +$126K +0.6% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $21.4M -$291K -1.34% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $19.7M -$2.67M -11.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $20.4M -$2.71M -11.7% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $20.9M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $21.7M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $22.4M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $23.1M +$21.7M +1548% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $1.4M Jan 1, 2020 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.